Moderna signs deal to make mRNA vaccines for Chinese market

SHANGHAI – Moderna will push toward producing messenger RNA vaccines for China, seeking a foothold in the world’s second-largest pharmaceutical market even as geopolitical tensions rise.

The Chinese financial hub is home to the mainland headquarters of several global pharmaceutical companies along with local biotech firms. Moderna will work with the local government to conduct clinical trials and apply to bring products to the market as well as to produce and sell them in China. Any medicines produced under the deal will be only for the Chinese market, targeting unmet needs for patients in the country and won’t be exported, Moderna said.

China, meanwhile, hasn’t approved any western Covid-19 vaccines, inoculating its 1.4 billion population largely with less potent inactivated shots developed by local companies.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Chinese smartphones sales exceed 70% of Russian marketChinese smartphones dominated the Russian market in the first half of 2023, exceeding 70 per cent of all sales, leading consumer electronics retailer M.Video-Eldorado said, up from about 55 per cent last year.Smartphones from Chinese retailers like Xiaomi and Realme have become top sellers in Russia after
출처: ChannelNewsAsia - 🏆 6. / 66 더 많은 것을 읽으십시오 »